CureVac COVID-19 vaccine

The CureVac COVID-19 vaccine is a COVID-19 vaccine candidate created by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). 
The vaccine showed bad results in its Phase III trials with only 47% effective.